The impact of everolimus versus mycophenolate on blood and lymphocyte cyclosporine exposure in heart-transplant recipients

被引：0
|
作者：
Finn Gustafsson
David Barth
Diego H. Delgado
Meerna Nsouli
Jill Sheedy
Heather J. Ross
机构：
[1] Toronto General Hospital,Heart Failure and Transplant, Division of Cardiology, University Health Network
[2] Toronto General Hospital,Department of Hematology, University Health Network
[3] Rigshospitalet 2142,Department of Cardiology
[4] Copenhagen University Hospital,undefined
来源：
European Journal of Clinical Pharmacology | 2009年 / 65卷
关键词：
Proliferation signal inhibitors; Rejection; Calcineurin inhibitors; Renal failure;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：659 / 665
页数：6
相关论文
共 50 条
  • [1] The impact of everolimus versus mycophenolate on blood and lymphocyte cyclosporine exposure in heart-transplant recipients
    Gustafsson, Finn
    Barth, David
    Delgado, Diego H.
    Nsouli, Meerna
    Sheedy, Jill
    Ross, Heather J.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (07) : 659 - 665
  • [2] The Survival of Heart Transplant Recipients Using Cyclosporine and Everolimus Is Not Inferior to That Using Cyclosporine and Mycophenolate
    Wang, S. -S.
    Chou, N. -K.
    Chi, N. -H.
    Huang, S. -C.
    Wu, I. -H.
    Wang, C. -H.
    Yu, H. -Y.
    Chen, Y. -S.
    Tsao, C. -I.
    Ko, W. -J.
    Shun, C. -T.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (03) : 938 - 939
  • [3] CYCLOSPORINE CHOLESTASIS IN HEART-TRANSPLANT RECIPIENTS
    SCHADE, RR
    VANTHIEL, DH
    GUGLIEMI, A
    WARTY, V
    SANGHVI, A
    BAHNSON, H
    THOMPSON, M
    HEPATOLOGY, 1983, 3 (05) : 828 - 828
  • [4] THE MANAGEMENT OF HEART-TRANSPLANT RECIPIENTS TREATED WITH CYCLOSPORINE
    KAHAN, BD
    TRANSPLANTATION PROCEEDINGS, 1983, 15 (04) : 2649 - 2661
  • [5] CARDIOVASCULAR EFFECTS OF CYCLOSPORINE IN HEART-TRANSPLANT RECIPIENTS
    SCOTT, JP
    HIGENBOTTAM, TW
    HUTTER, JA
    SMYTH, RL
    GLANDVILLE, C
    WALLWORK, J
    TRANSPLANTATION PROCEEDINGS, 1990, 22 (04) : 1740 - 1741
  • [6] CHOLESTASIS IN HEART-TRANSPLANT RECIPIENTS TREATED WITH CYCLOSPORINE
    SCHADE, RR
    GUGLIELMI, A
    VANTHIEL, DH
    THOMPSON, ME
    WARTY, V
    GRIFFITH, B
    SANGHVI, A
    BAHNSON, H
    HARDESTY, R
    TRANSPLANTATION PROCEEDINGS, 1983, 15 (04) : 2757 - 2760
  • [7] THE MANAGEMENT OF HEART-TRANSPLANT RECIPIENTS TREATED WITH CYCLOSPORINE IN IRELAND - MONITORING OF CYCLOSPORINE CONCENTRATIONS IN BLOOD
    KYNE, F
    MAGUIRE, S
    UACONAILL, D
    OBROIN, S
    CLARKE, E
    MCCANN, S
    DERVAN, P
    WOOD, AE
    IRISH JOURNAL OF MEDICAL SCIENCE, 1990, 159 (9-12) : 272 - 274
  • [8] CYCLOSPORINE AND CONVULSIONS IN A SERIES OF HEART-TRANSPLANT RECIPIENTS
    BAULAC, M
    SMADJA, D
    CABROL, A
    CABROL, C
    LAPLANE, D
    REVUE NEUROLOGIQUE, 1989, 145 (05) : 393 - 397
  • [9] RIFAMPICIN AND CYCLOSPORINE DOSING IN HEART-TRANSPLANT RECIPIENTS
    WANDEL, C
    BOHRER, H
    BOCKER, R
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 1995, 9 (05) : 621 - 622
  • [10] EFFECTS OF THE IMMUNOSUPPRESSANT CYCLOSPORINE ON THE CIRCULATION OF HEART-TRANSPLANT RECIPIENTS
    SCOTT, JP
    HIGENBOTTAM, TW
    HUTTER, JA
    LARGE, S
    WALLWORK, J
    AMERICAN JOURNAL OF CARDIOLOGY, 1991, 67 (07): : 628 - 632
12345